This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Prognostic and Diagnostic Evaluation

Jay P. Sanford, MD; Jack A. Barnett, MD

JAMA. 1965;192(7):587-592.

Abstract
Circulating antibodies develop in both experimental and clinical pyelonephritis. However, the relationship of such antibodies to antibacterial resistance is complex, and conclusions drawn from various observations have been controversial. In experimental pyelonephritis caused by gram-negative bacilli, preimmunization was protective; however, it was nullified by obstructive uropathy. Clinical assessment of antibody response has had two goals: determination of diagnostic value and assessment of protective effects. While a single hemagglutinin titer is of limited value, a significant rise in anti-0 hemagglutinin titer suggests pyelonephritis. In patients with cystitis, titers tend to remain stable. Immunity appears to play little role in recovery, but may be a determinant in selection of organisms involved in reinfection.

Author Affiliations
From the Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas.

Footnotes
Read before the 18th clinical convention of the American Medical Association, Miami Beach, Fla, Dec 1,1964.

Reprint requests to 5323 Harry Hines Blvd, Dallas 75235 (Dr. Sanford).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?